Literature DB >> 21214047

The additive effects of alcohol and benzodiazepines on driving.

Hillary G Maxwell1, Sacha Dubois, Bruce Weaver, Michel Bédard.   

Abstract

OBJECTIVES: To examine the relationship between the combination of alcohol and benzodiazepines and the risk of committing an unsafe driver action.
METHODS: We used data from the Fatality Analysis Reporting System (1993-2006) on drivers aged 20 or older who were tested for both alcohol and drugs. Using a case-control design, we compared drivers who had at least one unsafe driver action (UDA; e.g., weaving) recorded in relation to the crash (cases) to drivers who did not (controls).
RESULTS: Drivers who tested positive for intermediate- and long-acting benzodiazepines in combination with alcohol had significantly greater odds of a UDA compared to those under the influence of alcohol alone, up to blood alcohol concentrations (BACs) of 0.08 and 0.05 g/100 ml, respectively. The odds of a UDA with short-acting benzodiazepines combined with alcohol were no different than for alcohol alone.
CONCLUSIONS: This study demonstrates that the combination of alcohol and benzodiazepines can have detrimental effects on driving beyond those of alcohol alone. By describing these combined effects in terms of BAC equivalencies, this study also allows for the extrapolation of simple, concrete concepts that communicate risk to the average benzodiazepine user.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21214047      PMCID: PMC6973881     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  22 in total

1.  Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.

Authors:  M van Laar; E Volkerts; M Verbaten
Journal:  Psychopharmacology (Berl)       Date:  2001-03-01       Impact factor: 4.530

2.  Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects.

Authors:  J Vanakoski; M J Mattila; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  2000-09       Impact factor: 2.953

3.  Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.

Authors:  Luc Staner; Stéphane Ertlé; Peter Boeijinga; Gilbert Rinaudo; Marie Agnès Arnal; Alain Muzet; Rémy Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.

Authors:  Joris C Verster; Edmund R Volkerts; Marinus N Verbaten
Journal:  Neuropsychopharmacology       Date:  2002-08       Impact factor: 7.853

5.  Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.

Authors:  J F O'Hanlon; A Vermeeren; M M Uiterwijk; L M van Veggel; H F Swijgman
Journal:  Neuropsychobiology       Date:  1995       Impact factor: 2.328

6.  Repeated dose effects of lormetazepam and flurazepam upon driving performance.

Authors:  K A Brookhuis; E R Volkerts; J F O'Hanlon
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  The impact of benzodiazepines on safe driving.

Authors:  Sacha Dubois; Michel Bédard; Bruce Weaver
Journal:  Traffic Inj Prev       Date:  2008-10       Impact factor: 1.491

8.  Risk of traffic accident injury after a prescription for a benzodiazepine.

Authors:  C I Neutel
Journal:  Ann Epidemiol       Date:  1995-05       Impact factor: 3.797

Review 9.  Accident- and injury-related health-care utilization among benzodiazepine users and nonusers.

Authors:  G Oster; M W Russell; D M Huse; S F Adams; J Imbimbo
Journal:  J Clin Psychiatry       Date:  1987-12       Impact factor: 4.384

10.  The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes.

Authors:  Olaf H Drummer; Jim Gerostamoulos; Helen Batziris; Mark Chu; John Caplehorn; Michael D Robertson; Philip Swann
Journal:  Accid Anal Prev       Date:  2004-03
View more
  5 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 2.  Benzodiazepine harm: how can it be reduced?

Authors:  Malcolm Lader
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Differences in state drug testing and reporting by driver type in U.S. fatal traffic crashes.

Authors:  Megan E Slater; I-Jen P Castle; Barry K Logan; Ralph W Hingson
Journal:  Accid Anal Prev       Date:  2016-04-06

4.  Is blood alcohol level a good predictor for injury severity outcomes in motor vehicle crash victims?

Authors:  Bikaramjit Mann; Ediriweera Desapriya; Takeo Fujiwara; Ian Pike
Journal:  Emerg Med Int       Date:  2011-09-14       Impact factor: 1.112

5.  Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators.

Authors:  Andres D Ramirez; Anthony L Gotter; Steven V Fox; Pamela L Tannenbaum; Lihang Yao; Spencer J Tye; Terrence McDonald; Joseph Brunner; Susan L Garson; Duane R Reiss; Scott D Kuduk; Paul J Coleman; Jason M Uslaner; Robert Hodgson; Susan E Browne; John J Renger; Christopher J Winrow
Journal:  Front Neurosci       Date:  2013-12-24       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.